ABOUT CURAIT MEDICAL
The Operational Layer for Modern Radiation Therapy
Curait Medical builds the operational layer for modern radiation therapy. Our platform, Complai, is fully end to end, supporting the entire radiation therapy workflow from clinical processes to outcomes tracking, billing, and financial analysis. Complai standardizes how departments work, strengthens consistency across clinicians and sites, and gives leaders a clear view of quality, performance, and economics.
Leading cancer centers must solve the growing operational pressure created by rising cancer volumes and adaptive therapy. Our mission is to equip radiation treatment services with the infrastructure they need to deliver safe, efficient, and financially sustainable care with increased quality, greater efficiency and throughput, all with lower costs.
LEADERSHIP & TRACK RECORD
Proven Team with Serial Exit Success
First to invent, publish, and patent Quality X-AI technology in radiation treatment.
Chief Executive Officer
20+ years of Medtech commercialization, sales, and operations culminating in two successful exits exceeding $200M in cumulative value.
Chief Scientific Officer
Medical Physicist at Princess Margaret Hospital. Pioneer in commercialized X-AI Quality technology for RT; invented and patented the core IP.
Chief Technology Officer
X-AI Computer Scientist at University of Toronto. Recognized globally for inventing, publishing, and patenting X-AI quality software in oncology.
Faruq Rashid, CPA, MBA
Chief Financial Officer
20+ years in technology finance, financial modeling, early-stage capital structuring, and high-growth commercial scaling.
David Blaszczak
Health Economics & Reimbursement Advisor
20+ years Medtech market access & payer contracting expert. Architect of Curait’s US AI CPT code strategy.
Roger Davis
General Counsel
20+ years negotiating complex technology licensing and acquisitions with regulatory-sensitive compliance policies.
UPDATES & PRESS
Latest News
Follow our latest updates, pitch competitions, and presentations at major radiation oncology conferences.
Curait Medical: Finalist at the GHIS III International Pitch Competition
September 16, 2026
Curait Medical was selected as a finalist at the Global Health Innovators Summit III International Pitch Competition on September 16, 2026, in Nashville, TN. Steven Chackowicz presented at The Cannery, highlighting how Curait Medical's AI platform substantially improves radiation therapy, enhances accuracy, and efficiency in cancer treatment, all at a lower cost.
Read the full press release
Curait Medical: ASTRO 2026 Quick Pitch Oral Selection
August 29, 2026
Curait Medical was selected for a Quick Pitch Oral Presentation at ASTRO 2026 in Boston, ranking in the top 10% of 2,700+ submissions. Presented by Jeff Winter, the talk highlights how the Complai™ platform uses interpretable AI to streamline quality in adaptive radiotherapy.
Read the full press releaseLearn more about Curait Medical
